Generic name: bendroflumethiazide
Dosage form: Tablets USP
Medically reviewed on February 22, 2018.
Therapy should be individualized according to patient response and titrated to obtain maximal therapeutic response as well as the lowest dose possible to maintain that therapeutic response and minimize side effects.
The usual dose is 5 mg once daily, preferably given in the morning. To initiate therapy, doses up to 20 mg may be given once daily or divided into two doses. A single daily dose of 2.5 to 5 mg should suffice for maintenance.
Alternatively, intermittent therapy may be advantageous in many patients. By administering the preparation every other day or on a three to five day per week schedule, electrolyte imbalance is less likely to occur; however, the possibility still exists.
In general, the lowest dosage that achieves the therapeutic response should be employed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.